Researchers assess cognitive impairment in patients with breast cancer

breast cancer
Credit: CC0 Public Domain

A recent analysis of published studies estimates that one-quarter of adults with breast cancer have cognitive impairment before starting therapy. The analysis, which is published in Psycho-Oncology, also found that many patients' cognitive function declines after receiving chemotherapy, endocrine therapy, and/or hormone therapy for breast cancer.

"Our results suggest that cancer-related and personal factors may make a significant contribution to cognitive functioning," said lead author Aicha Dijkshoorn, of the University Medical Center Utrecht, in the Netherlands.

The authors noted that the findings from different studies were quite diverse, and some even reported cognitive improvements in patients after treatment. They stressed the importance of evaluating and addressing cognitive function, ideally over time, in patients with .

World Cancer Day is February 4th.

Explore further

Researchers discover potential new therapy for chemotherapy-resistant breast cancer

More information: Psycho-Oncology (2021). DOI: 10.1002/pon.5623
Journal information: Psycho-Oncology

Provided by Wiley
Citation: Researchers assess cognitive impairment in patients with breast cancer (2021, February 3) retrieved 25 May 2022 from
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.

Feedback to editors